Wave Health demonstrates the feasibility of using its platform to monitor electronic patient-reported outcomes (ePROs) in prostate cancer patients. The study, published in *ESMO’s Real World Data and Digital Oncology Journal*, explores how digital tools can track symptoms and quality of life metrics remotely. Findings validate the integration of ePROs into clinical workflows for prostate cancer management.
Treatment Technologies & Insights (TTI) uses its **Wave Health** ePRO app to collect real-world patient-reported symptoms and side effects in immunotherapy trials. The study’s findings are now featured in **two abstracts** at the 2023 American Society of Clinical Oncology (ASCO) conference. TTI’s digital platform facilitates direct patient input, improving data accuracy in cancer treatment research.
Treatment Technologies & Insights (TTI) launches a pilot study at the **Seattle Cancer Care Alliance** to assess patient-reported outcomes in long-term immunotherapy patients. The research examines chronic symptoms experienced during extended immunotherapy treatment. Findings aim to improve understanding of treatment impacts for cancer patients undergoing prolonged care.